Ratings by BTIG (Sung Ji Nam)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2026 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2025 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2025 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2025 | CareDx, Inc | CDNA | Maintain | Buy (Buy) |
|
Details | ||
| 8/13/2025 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2025 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2025 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2024 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2024 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | CareDx, Inc | CDNA | Maintain | Buy (Buy) |
|
Details | ||
| 8/19/2024 | CareDx, Inc | CDNA | Upgrade | Buy (Neutral) |
33.00 (28.51) |
-13.61% | Details | |
| 8/6/2024 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2024 | DermTech Inc. | DMTK | Downgrade | Neutral (Buy) |
0.59 (0.09) |
-84.75% | Details | |
| 3/6/2024 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2023 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2023 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | CareDx, Inc | CDNA | Downgrade | Neutral (Buy) |
8.59 (33.00) |
284.17% | Details | |
| 5/4/2023 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2022 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2022 | Quotient | QTNT | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2022 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2022 | Genetron Holdings Inc. | GTH | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2022 | Bionano Genomics | BNGO | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2022 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2021 | Quotient | QTNT | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2021 | Genetron Holdings Inc. | GTH | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2021 | Fluidigm Corporation | FLDM | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2021 | Centogene NV | CNTG | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2021 | Biodesix | BDSX | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2021 | DermTech Inc. | DMTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2021 | Alpha Teknova Inc. | TKNO | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2021 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2021 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2021 | Biodesix | BDSX | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2021 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2021 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2021 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2021 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2021 | Alpha Teknova Inc. | TKNO | New Coverage | Buy (N/A) |
18.06 (5.36) |
-70.32% | Details | |
| 7/20/2021 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2021 | Bionano Genomics | BNGO | New Coverage | Buy (N/A) |
7.37 (1.20) |
-83.72% | Details | |
| 5/11/2021 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2021 | Fluidigm Corporation | FLDM | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2021 | Olink Holding AB | OLK | New Coverage | Buy (N/A) |
37.50 (26.08) |
-30.45% | Details | |
| 4/13/2021 | Luminex | LMNX | Downgrade | Neutral (Buy) |
37.03 (18.59) |
-49.8% | Details | |
| 3/4/2021 | Quanterix Corp. | QTRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | Illumina | ILMN | Upgrade | Buy (Neutral) |
353.32 (190.20) |
-46.17% | Details | |
| 11/24/2020 | Fulgent Genetics | FLGT | Downgrade | Neutral (Buy) |
43.60 (20.55) |
-52.87% | Details | |
| 11/23/2020 | Biodesix | BDSX | New Coverage | Buy (N/A) |
17.09 (21.42) |
25.34% | Details | |
| 11/4/2020 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2020 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2020 | Progenity Inc. | PROG | New Coverage | Buy (N/A) |
7.80 (0.88) |
-88.72% | Details | |
| 8/6/2020 | Luminex | LMNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Quanterix Corp. | QTRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | CareDx, Inc | CDNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2020 | GenMark Diagnostics | GNMK | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2020 | Fulgent Genetics | FLGT | New Coverage | Buy (N/A) |
16.06 (43.60) |
171.48% | Details | |
| 5/7/2020 | Myriad Genetics | MYGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2020 | Centogene NV | CNTG | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2020 | Myriad Genetics | MYGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/31/2020 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2019 | Waters Corp. | WAT | Downgrade | Neutral (Buy) |
221.36 (376.43) |
70.05% | Details | |
| 12/2/2019 | Centogene NV | CNTG | New Coverage | Buy (N/A) |
12.97 (0.33) |
-97.46% | Details | |
| 11/11/2019 | Luminex | LMNX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2019 | Fluidigm Corporation | FLDM | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2019 | Castlight | CSTL | New Coverage | Buy (N/A) |
20.25 (23.72) |
17.14% | Details | |
| 8/7/2019 | Quanterix Corp. | QTRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2019 | Fluidigm Corporation | FLDM | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2019 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2019 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2019 | Quanterix Corp. | QTRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2019 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2019 | Waters Corp. | WAT | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2019 | Thermo Fisher Scientific | TMO | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2019 | Fluidigm Corporation | FLDM | New Coverage | Buy (N/A) |
12.07 (3.71) |
-69.26% | Details | |
| 3/12/2019 | Oxford Immunotec | OXFD | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2019 | Quanterix Corp. | QTRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2019 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2019 | Waters Corp. | WAT | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2018 | Myriad Genetics | MYGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2018 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2018 | Oxford Immunotec | OXFD | Maintain | (N/A) |
|
Details | ||
| 8/22/2018 | Myriad Genetics | MYGN | Maintain | Buy (N/A) |
|
Details |
